IBM uses AI to predict progress of Huntington's disease
It could help with patient care and, hopefully, treatment.
IBM is using its AI-based health prediction skills to help tackle the
challenge of Huntington's disease. The tech firm has teamed up with
CHDI Foundation on an artificial intelligence model that can predict
when patients will experience Huntington's symptoms and, crucially,
determine how rapidly those symptoms will progress. The team used
MRI brain scans to train the AI, using signals from white matter (relatively
untapped in brain studies) to help the system gauge how cognitive and
motor performance will change over time.